What We Learned From the CannTrust (TSX:TRST) Scandal

Here is one important lesson to take away from the recent drama surrounding CannTrust Holdings Inc (TSX:TRST)(NYSE:CTST).

Person Hands Opening Mailbox To Remove Newspaper

Image source: Getty Images

While cannabis stocks have not performed well since early April, the month of July was especially brutal for the sector. There is no doubt that the drama surrounding CannTrust Holdings (TSX:TRST)(NYSE:CRST) had a lot to do with this catastrophic performance. However, there may be a silver lining — or at least an important lesson to glean — from this scandal, one of the many that have rocked the marijuana sector in the past few months. 

Reviewing the CannTrust debacle 

Despite marijuana now being legal in Canada, companies that engage in the cultivation, processing, and sale of various strains of cannabis have to abide by some strict regulations. These regulations include obtaining a licence for all the marijuana-related activity a firm plans to engage in. Obviously, failure to comply with these laws can result in severe consequences. That is precisely the situation CannTrust is currently facing. A Health Canada inspection at one of the firm’s Ontario facilities revealed that CannTrust grew cannabis in unlicensed rooms for months. 

Although these rooms eventually received the green light necessary for cultivation, that still constitutes a violation. That wasn’t the end of the matter, though, as another inspection at another facility was found to be in transgression of several regulations. According to a report, CannTrust converted several rooms into storage areas and constructed two new areas in the facility without obtaining permission. Further, the company did not maintain the proper security measures in the facility and did not keep documents in such a way as to allow Health Canada to “complete its audit in a timely manner.”

A warning to investors 

The situation surrounding CannTrust is far from being resolved. The firm made several moves to gain the trust of investors back. Not only did the company’s CEO resign — a necessary step in the process of leaving this unfortunate episode behind — but CannTrust also formed a special committee to investigate these violations. Investors are now waiting to see what sanctions will be imposed on the company.

This is yet another reminder that the stringent marijuana regulations will be an obstacle moving forward — something investors have to constantly keep in mind. Take our neighbors to the south for instance. The marijuana market in the U.S. will likely be exponentially larger than that of Canada. But the laws in the U.S. are even more complicated. 

Many local and state governments have legalized medical or recreational uses of marijuana, but the federal government still considers it a schedule one substance. As a result, it is illegal to transport marijuana across state lines, which puts added pressure on companies to grow the necessary products they need within a particular state. Of course, the passage of the Farm Bill at the end of last year was a big deal. Hemp and hemp-derived products are now legal in the U.S. However, even this market is heavily regulated, as Curaleaf Holdings recently found out. Investors looking to jump on the cannabis bandwagon have to price this important factor into their valuation of cannabis stocks. 

The bottom line

Just a few months ago, CannTrust seemed like an excellent prospect due to its ability to grow marijuana at very low costs (among other things). Shareholders couldn’t have predicted this drama would befall the firm, and they now have to deal with the aftermath. Even if a cannabis company isn’t directly caught in such a scandal, it could still be negatively affected if one of its peers is. In short, it is essential to proceed within the cannabis industry with extreme caution. 

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Prosper Bakiny has no position in any of the stocks mentioned.

More on Cannabis Stocks

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Are Cannabis Stocks Still a Thing in 2023?

The whole question of whether cannabis stocks are still relevant in 2023 is an interesting one. Here's my take on…

Read more »

A cannabis plant grows.
Cannabis Stocks

Why Canopy Growth Stock Fell 72% Last Year

Canopy Growth stock is a beaten-up cannabis giant that is trading at a discount compared to historical multiples. But is…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is SNDL Stock a Buy in January 2023?

SNDL is among the worst-performing cannabis stocks in the last three years. But is SNDL stock a buy right now?

Read more »

a person watches a downward arrow crash through the floor
Cannabis Stocks

Why Tilray Stock Fell Almost 60% in 2022

Tilray is a Canadian cannabis stock that is down 93% from all-time highs. Let's see if TLRY stock is a…

Read more »